Latest filings (excl ownership)
EFFECT
Notice of effectiveness
25 Apr 24
ARS
2023 FY
Annual report to shareholders
19 Apr 24
DEF 14A
Definitive proxy
19 Apr 24
PRE 14A
Preliminary proxy
9 Apr 24
8-K
Departure of Directors or Certain Officers
2 Apr 24
8-K
Other Events
27 Mar 24
8-K/A
Results of Operations and Financial Condition
12 Mar 24
S-3
Shelf registration
11 Mar 24
10-K
2023 FY
Annual report
11 Mar 24
8-K
Assertio Reports Fourth Quarter and Full Year 2023 Financial Results
11 Mar 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
23 Feb 24
8-K
Departure of Directors or Certain Officers
26 Jan 24
8-K
Departure of Directors or Certain Officers
5 Jan 24
8-K
Departure of Directors or Certain Officers
14 Nov 23
10-Q
2023 Q3
Quarterly report
8 Nov 23
8-K
Assertio Reports Third Quarter 2023 Financial Results
8 Nov 23
8-K/A
Completion of Acquisition or Disposition of Assets
10 Oct 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
8-K
Assertio Reports Second Quarter 2023 Financial Results, Closes Spectrum Acquisition
3 Aug 23
8-K
Assertio Holdings, Inc Announces Favorable Vote on Proposed Acquisition of Spectrum Pharmaceuticals
31 Jul 23
CT ORDER
Confidential treatment order
18 Jul 23
EFFECT
Notice of effectiveness
16 Jun 23
424B3
Prospectus supplement
15 Jun 23
8-K
Amendments to Articles of Incorporation or Bylaws
14 Jun 23
CORRESP
Correspondence with SEC
13 Jun 23
UPLOAD
Letter from SEC
9 Jun 23
S-4
Registration of securities issued in business combination transactions
1 Jun 23
S-8
Registration of securities for employees
15 May 23
8-K
Departure of Directors or Certain Officers
15 May 23
425
Business combination disclosure
9 May 23
10-Q
2023 Q1
Quarterly report
9 May 23
425
Business combination disclosure
9 May 23
8-K
Assertio Reports First Quarter 2023 Financial Results, Raises Full Year 2023 Outlook
9 May 23
425
Business combination disclosure
25 Apr 23
8-K
Regulation FD Disclosure
25 Apr 23
425
Business combination disclosure
25 Apr 23
8-K
Assertio Holdings, Inc. to Acquire Spectrum Pharmaceuticals, Inc. in All Stock and CVR Transaction
25 Apr 23
ARS
2022 FY
Annual report to shareholders
3 Apr 23
DEF 14A
Definitive proxy
3 Apr 23
Latest ownership filings
3
Sigurd Kirk
9 Apr 24
4
James L Tyree
15 Mar 24
144
Notice of proposed sale of securities
14 Mar 24
4
Sam Schlessinger
23 Feb 24
4
Paul Schwichtenberg
23 Feb 24
4
Ajay Patel
23 Feb 24
SC 13G
Nantahala Capital Management, LLC
14 Feb 24
SC 13G/A
CONTINENTAL GENERAL INSURANCE CO
14 Feb 24
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 24
4
Sam Schlessinger
13 Feb 24
4
Paul Schwichtenberg
13 Feb 24
4
Ajay Patel
13 Feb 24
SC 13G
VANGUARD GROUP INC
13 Feb 24
4
Sam Schlessinger
9 Feb 24
4
Paul Schwichtenberg
9 Feb 24
4
Ajay Patel
9 Feb 24
SC 13G
BlackRock Inc.
26 Jan 24
4
Heather L Mason
4 Jan 24
4
Sravan Kumar Emany
16 Nov 23
3
Sravan Kumar Emany
16 Nov 23
4
Sam Schlessinger
3 Oct 23
4
Sam Schlessinger
13 Sep 23
4
Ajay Patel
13 Sep 23
4
Paul Schwichtenberg
13 Sep 23
4
Daniel A. Peisert
13 Sep 23
144
Notice of proposed sale of securities
12 Sep 23
144
Notice of proposed sale of securities
11 Sep 23
144
Notice of proposed sale of securities
11 Sep 23
144
Notice of proposed sale of securities
11 Sep 23
144
Notice of proposed sale of securities
11 Sep 23
4
WILLIAM MCKEE
15 Aug 23
144
Notice of proposed sale of securities
14 Aug 23
4
Sam Schlessinger
8 Aug 23
4
Jeff L Vacirca
2 Aug 23
3
Jeff L Vacirca
2 Aug 23
4
Heather L Mason
22 May 23
144
Notice of proposed sale of securities
19 May 23
4
Sam Schlessinger
15 May 23
4
Ajay Patel
15 May 23
4
Paul Schwichtenberg
15 May 23